Heisz Leslie Stone - 08 Feb 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
Director
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
08 Feb 2024
Net transactions value
-$349,884
Form type
4
Filing time
08 Feb 2024, 18:08:07 UTC
Previous filing
10 Aug 2023
Next filing
06 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $260,107 +7,056 +26% $36.86 34,036 08 Feb 2024 Direct
transaction EW Common Stock Sale $609,991 -7,056 -21% $86.45 26,980 08 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Director Stock Option (Right to Acquire) Options Exercise $0 -7,056 -100% $0.000000* 0 08 Feb 2024 Common Stock 7,056 $36.86 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.